Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuka Harada

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Therapy-related myeloid neoplasms]Yuka Harada, Hironori Harada
Cancer Science|January 23, 2015
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapiesHironori Harada, Yuka Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2016
[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]Yuka Harada, Hironori Harada
Journal of Cellular Biochemistry|January 27, 2011
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutationsYuka Harada, Hironori Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute promyelocytic leukemia]Yuka Harada, Hironori Harada
Journal of Cellular Physiology|April 1, 2009
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutationsYuka Harada, Hironori Harada
Critical Reviews in Eukaryotic Gene Expression|January 5, 2006
Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndromeHironori Harada, Yuka Harada
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes]Hironori Harada, Yuka Harada, Akiro Kimura
Leukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori Harada
Scientific Reports|August 21, 2019
A TLR-CXCL1 pathway in DRG neurons induces neutrophil accumulation in the DRG and mechanical allodynia in EAE miceJing Zhang, Yuka Harada, Yoshinori Hayashi
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 9, 2012
[Therapy-related myeloid neoplasms]Yuka Harada, Hironori Harada
Cancer Science|January 23, 2015
Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapiesHironori Harada, Yuka Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 4, 2016
[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment]Yuka Harada, Hironori Harada
Journal of Cellular Biochemistry|January 27, 2011
Molecular mechanisms that produce secondary MDS/AML by RUNX1/AML1 point mutationsYuka Harada, Hironori Harada
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Acute promyelocytic leukemia]Yuka Harada, Hironori Harada
Journal of Cellular Physiology|April 1, 2009
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutationsYuka Harada, Hironori Harada
Critical Reviews in Eukaryotic Gene Expression|January 5, 2006
Point mutations in the AML1/RUNX1 gene associated with myelodysplastic syndromeHironori Harada, Yuka Harada
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 29, 2009
[Molecular mechanisms in myeloproliferative diseases and myelodysplastic syndromes]Hironori Harada, Yuka Harada, Akiro Kimura
Leukemia|March 31, 2022
Myeloid neoplasms and clonal hematopoiesis from the RUNX1 perspectiveYoshihiro Hayashi, Yuka Harada, Hironori Harada
Scientific Reports|August 21, 2019
A TLR-CXCL1 pathway in DRG neurons induces neutrophil accumulation in the DRG and mechanical allodynia in EAE miceJing Zhang, Yuka Harada, Yoshinori Hayashi
Pageof 13